跳到主要內容

Monte Rosa Therapeutics, Inc.

GLUE
交易所
Nasdaq
產業
Biological Products, (No Diagnostic Substances)
SEC CIK
0001826457

近 90 天,Monte Rosa Therapeutics, Inc. 內部人申報 0 筆公開市場買進、3 筆賣出;2026 年第 2 季末有 192 家機構在 13F 申報持有,市值合計 $22.4 億;大師中只有杜肯家族辦公室持有。

2021 年第 2 季與 2021 年第 1 季比較

持有 Monte Rosa Therapeutics, Inc. 的機構從 2021 年第 1 季到 2021 年第 2 季的變化。

2021 年第 2 季全部持有人2021 年第 1 季全部持有人

GLUE 的 13F 持有人:2021 年第 1 季與 2021 年第 2 季比較
項目2021 年第 1 季2021 年第 2 季變化
持有家數048+48
股數03,210 萬+3,210 萬
市值$0$7.05 億+$7.05 億

新進機構(48 家)

2021 年第 2 季季末持有 Monte Rosa Therapeutics, Inc.、2021 年第 1 季季末沒有持有的機構。

2021 年第 2 季新進 GLUE 的機構
機構股數市值佔組合 %
NEA Management Company, LLC7,703,205$1.75 億2.28%
FMR LLC4,312,259$9,355 萬0.01%
Cormorant Asset Management, LP3,193,973$6,955 萬2.71%
Avoro Capital Advisors LLC3,311,434$6,215 萬1.08%
Price T Rowe Associates Inc2,737,654$6,128 萬0.01%
BlackRock Inc.1,549,885$3,518 萬0.00%
Aisling Capital Management LP1,472,331$3,342 萬5.35%
Alphabet Inc.1,464,015$3,323 萬0.68%
RTW Investments, LP1,214,572$2,523 萬0.38%
Casdin Capital, LLC960,883$2,181 萬0.55%
Deerfield Management Company, L.P. (Series C)350,000$794.5 萬0.14%
OrbiMed Advisors LLC350,000$794.5 萬0.08%
Jennison Associates LLC300,000$681.0 萬0.00%
Avidity Partners Management LP300,000$681.0 萬0.18%
Logos Global Management LP300,000$681.0 萬0.58%
Octagon Capital Advisors LP238,045$540.4 萬1.12%
Millennium Management LLC235,102$533.7 萬0.01%
Woodline Partners LP208,068$472.3 萬0.09%
Suvretta Capital Management, LLC150,000$340.5 萬0.05%
Alliancebernstein L.P.139,095$315.7 萬0.00%
Sectoral Asset Management Inc129,633$294.3 萬0.24%
Ratan Capital Management LP120,000$272.4 萬0.24%
Monashee Investment Management LLC120,000$272.4 萬0.33%
Goldman Sachs Group Inc108,500$246.3 萬0.00%
Voya Investment Management LLC104,177$236.4 萬0.00%
Vanguard Group Inc100,000$227.0 萬0.00%
HealthCor Management, L.P.100,000$227.0 萬0.09%
Sphera Funds Management Ltd.100,000$227.0 萬0.22%
Pura Vida Investments, LLC100,000$227.0 萬0.16%
Citadel Advisors LLC95,792$217.4 萬0.00%
Soleus Capital Management, L.P.75,000$170.3 萬0.26%
LMR Partners LLP58,500$132.8 萬0.02%
Hound Partners, LLC49,995$113.5 萬0.06%
Alyeska Investment Group, L.P.50,000$113.5 萬0.01%
Caas Capital Management LP50,000$113.5 萬0.06%
Pinz Capital Management, LP43,700$99.2 萬0.30%
TD Asset Management Inc38,764$95.0 萬0.00%
Norges Bank30,000$68.1 萬0.00%
Squarepoint Ops LLC28,209$64.0 萬0.00%
Point72 Asset Management, L.P.25,000$56.8 萬0.00%
Ghisallo Capital Management LLC20,000$45.4 萬0.02%
Qube Research & Technologies Ltd13,100$29.7 萬0.00%
Point72 Hong Kong Ltd10,606$24.1 萬0.02%
Tudor Investment Corp Et Al10,000$22.7 萬0.00%
Maven Securities LTD11,106$21.3 萬0.02%
Wellington Management Group LLP9,192$20.9 萬0.00%
Legal & General Group Plc3,000$6.90 萬0.00%
Tower Research Capital LLC (TRC)400$9,0000.00%

清倉機構(0 家)

2021 年第 1 季季末持有 Monte Rosa Therapeutics, Inc.、2021 年第 2 季有申報但已經沒有持有的機構。

沒有。